Single-molecule functional anatomy of endogenous HER2-HER3 heterodimers
Open Access
- 8 April 2020
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Abstract
Human epidermal growth factor receptors (HERs) are the primary targets of many directed cancer therapies. However, the reason a specific dimer of HERs generates a stronger proliferative signal than other permutations remains unclear. Here, we used single-molecule immunoprecipitation to develop a biochemical assay for endogenously-formed, entire HER2-HER3 heterodimers. We observed unexpected, large conformational fluctuations in juxta-membrane and kinase domains of the HER2-HER3 heterodimer. Nevertheless, the individual HER2-HER3 heterodimers catalyze tyrosine phosphorylation at an unusually high rate, while simultaneously interacting with multiple copies of downstream signaling effectors. Our results suggest that the high catalytic rate and multi-tasking capability make a concerted contribution to the strong signaling potency of the HER2-HER3 heterodimers.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2011-0018352)
- National Research Foundation of Korea (NRF-2018M3A9E2023523)
This publication has 64 references indexed in Scilit:
- Conformational Coupling across the Plasma Membrane in Activation of the EGF ReceptorCell, 2013
- Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF ReceptorCell, 2010
- In Vitro Enzymatic Characterization of Near Full Length EGFR in Activated and Inhibited StatesBiochemistry, 2009
- The Juxtamembrane Region of the EGF Receptor Functions as an Activation DomainMolecular Cell, 2009
- Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane SegmentCell, 2009
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941Cancer Cell, 2009
- Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor SensitivityCancer Cell, 2007
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular DomainsCell, 2002
- Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor αCell, 2002